Evaluating the Cost and Prevalence of Endometriosis in Hungary
Author Information
Author(s): Pónusz-Kovács Dalma, Pónusz Róbert, Sántics-Kajos Luca Fanni, Csákvári Tímea, Kovács Bettina, Várnagy Ákos, Kovács Kálmán András, Bódis József, Boncz Imre
Primary Institution: University of Pécs
Hypothesis
The study aims to analyze the prevalence and annual health insurance treatment costs of endometriosis in Hungary for the years 2010 and 2019.
Conclusion
The number of endometriosis cases is increasing, and early diagnosis along with targeted treatment could improve patients' quality of life and reduce health insurance costs.
Supporting Evidence
- The prevalence of endometriosis increased from 101.9 to 197.3 per 100,000 women between 2010 and 2019.
- Health insurance expenditure for endometriosis treatment rose from EUR 1,639,612 in 2010 to EUR 1,905,476 in 2019.
- Patients aged 30-39 years represented the highest prevalence of endometriosis in both years studied.
Takeaway
Endometriosis is becoming more common in Hungary, and treating it early can help women feel better and save money on healthcare.
Methodology
The study used a retrospective database analysis of nationwide health insurance data from Hungary for the years 2010 and 2019.
Potential Biases
Potential bias due to underreporting of cases in private healthcare settings.
Limitations
The study only analyzed publicly funded healthcare data and did not include private sector information.
Participant Demographics
The study focused on women of reproductive age, particularly those aged 30-39 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 34.3–42.2 for 2010; 95% CI: 36.3–42.9 for 2019
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website